Package 76420-047-60

{"route": ["ORAL"], "spl_id": "e35b53ce-ead2-6007-e053-2995a90a7f25", "openfda": {"nui": ["N0000008486"], "unii": ["6CW7F3G59X"], "rxcui": ["310431", "310432"], "spl_set_id": ["14b1840d-a2db-4eec-bc25-029e35b042e4"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "120 CAPSULE in 1 BOTTLE (76420-047-12)", "package_ndc": "76420-047-12", "marketing_start_date": "20220707"}, {"sample": false, "description": "240 CAPSULE in 1 BOTTLE (76420-047-24)", "package_ndc": "76420-047-24", "marketing_start_date": "20200903"}, {"sample": false, "description": "30 CAPSULE in 1 BOTTLE (76420-047-30)", "package_ndc": "76420-047-30", "marketing_start_date": "20200903"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (76420-047-60)", "package_ndc": "76420-047-60", "marketing_start_date": "20200903"}, {"sample": false, "description": "90 CAPSULE in 1 BOTTLE (76420-047-90)", "package_ndc": "76420-047-90", "marketing_start_date": "20200903"}], "brand_name": "Gabapentin", "product_id": "76420-047_e35b53ce-ead2-6007-e053-2995a90a7f25", "dosage_form": "CAPSULE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "76420-047", "generic_name": "Gabapentin", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gabapentin", "active_ingredients": [{"name": "GABAPENTIN", "strength": "300 mg/1"}], "application_number": "ANDA090858", "marketing_category": "ANDA", "marketing_start_date": "20110129", "listing_expiration_date": "20261231"}